153 related articles for article (PubMed ID: 11811215)
21. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
22. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
[No Abstract] [Full Text] [Related]
23. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
24. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
25. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
Sendur OF; Turan Y; Berkit IK; Tastaban E
Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
[TBL] [Abstract][Full Text] [Related]
26. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
27. Etanercept-associated right abducens nerve palsy in rheumatoid arthritis.
Lai CC; Hsiao KH; Chang YS; Tsai CY; Chou CT
Int J Rheum Dis; 2012 Oct; 15(5):e117-9. PubMed ID: 23083045
[No Abstract] [Full Text] [Related]
28. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
Uthman I; Husari A; Touma Z; Kanj SS
Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
[No Abstract] [Full Text] [Related]
29. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
30. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
Hall HA; Zimmermann B
Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
[No Abstract] [Full Text] [Related]
31. Etanercept (Enbrel) -- an update.
Goffe B
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
[TBL] [Abstract][Full Text] [Related]
32. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
[TBL] [Abstract][Full Text] [Related]
33. Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment.
Lewicki M; Kotyla P; Kucharz E
J Rheumatol; 2009 Jun; 36(6):1346-7; author reply 1347. PubMed ID: 19509093
[No Abstract] [Full Text] [Related]
34. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
35. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M
G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399
[No Abstract] [Full Text] [Related]
36. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.
Lindsay K; Melsom R; Jacob BK; Mestry N
Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195
[No Abstract] [Full Text] [Related]
37. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
38. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
Duffy TN; Genta M; Moll S; Martin PY; Gabay C
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
[No Abstract] [Full Text] [Related]
39. Etanercept allergy and anaphylaxis.
Quismorio A; Brahmbhatt B; Houng M; Panush RS
J Rheumatol; 2012 Nov; 39(11):2225-6. PubMed ID: 23118296
[No Abstract] [Full Text] [Related]
40. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
